Covalon Technologies Ltd. (CVALF)

Market Cap	48.76M
Revenue (ttm)	24.10M
Net Income (ttm)	3.29M
Shares Out	n/a
EPS (ttm)	0.12
PE Ratio	14.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	7,029
Open	1.780
Previous Close	1.730
Day's Range	1.780 - 1.835
52-Week Range	0.740 - 3.080
Beta	0.45
RSI	59.04
Earnings Date	May 28, 2025

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by second...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 37
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVALF

Financial Performance

Financial numbers in CAD